rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-1-11
|
pubmed:abstractText |
We tested a sequential combination regimen using cisplatin and vinorelbine (PVn) followed by docetaxel as first-line chemotherapy in a phase II clinical trial in metastatic breast cancer (MBC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0030-2414
|
pubmed:author |
pubmed-author:Abdel-KhalekZeinaZ,
pubmed-author:BitarNizarN,
pubmed-author:CharafeddineMayaM,
pubmed-author:ChehalArefA,
pubmed-author:DandashiAzzamA,
pubmed-author:DheinyMoussaM,
pubmed-author:El-SaghirNagi SNS,
pubmed-author:JalloulRahifR,
pubmed-author:KhalifehMohamad JMJ,
pubmed-author:OtrockZaher KZK,
pubmed-author:ShamseddineAli IAI,
pubmed-author:WehbehMahmoudM,
pubmed-author:YassineHanan RHR
|
pubmed:copyrightInfo |
Copyright 2006 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
330-8
|
pubmed:meshHeading |
pubmed-meshheading:17164589-Adult,
pubmed-meshheading:17164589-Aged,
pubmed-meshheading:17164589-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17164589-Breast Neoplasms,
pubmed-meshheading:17164589-Cisplatin,
pubmed-meshheading:17164589-Disease Progression,
pubmed-meshheading:17164589-Disease-Free Survival,
pubmed-meshheading:17164589-Drug Administration Schedule,
pubmed-meshheading:17164589-Female,
pubmed-meshheading:17164589-Fever,
pubmed-meshheading:17164589-Follow-Up Studies,
pubmed-meshheading:17164589-Humans,
pubmed-meshheading:17164589-Kidney,
pubmed-meshheading:17164589-Middle Aged,
pubmed-meshheading:17164589-Neoplasm Staging,
pubmed-meshheading:17164589-Neutropenia,
pubmed-meshheading:17164589-Survival Analysis,
pubmed-meshheading:17164589-Taxoids,
pubmed-meshheading:17164589-Treatment Outcome,
pubmed-meshheading:17164589-Vinblastine,
pubmed-meshheading:17164589-Vomiting
|
pubmed:year |
2006
|
pubmed:articleTitle |
A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.
|
pubmed:affiliation |
American University of Beirut Medical Center, Beirut, Lebanon. as04@aub.edu.lb
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|